Sex Differences in Cognition Don't Fade With Age — They Persist Into the 80s

The study, led by Julian and colleagues and published in GeroScience, examined 131 adults between the ages of 80 and 92, an age band that is notoriously thin in the cognitive-aging literature. Using confirmatory factor analysis, the team distilled 17 separate cognitive measures into two broad components — executive functioning and memory — then asked a deceptively simple question: do the sex differences documented in younger adults still hold here, at the far end of the life course? And if so, can circulating sex hormones explain them? Their findings point in a direction that warrants attention without overstatement.

On both cognitive components, women outperformed men. Not by a sliver, and not in a way the authors attributed to chance. The female advantage in memory — already well established in midlife — appeared to carry forward intact. More surprising was the executive-function result: the mental machinery of planning, switching, and inhibition, often assumed to converge between the sexes with age, also favored women in this older cohort.

If women still hold a cognitive edge into their 80s, the intuitive next question is whether sex hormones are doing the work. Estrogen, after all, has a long and contested history in brain research — implicated in everything from verbal memory to neuroinflammation to dementia risk. Testosterone has its own literature, less developed but plausibly relevant.

Here the GeroScience team produced a more nuanced result. When they ran mediation analyses to ask whether circulating estrogen or testosterone could account for the sex differences they observed, the hormones did not, in fact, mediate the effect. Being female predicted better executive function and memory; current hormone levels did not explain why. That is a meaningful nuance. It means whatever drives the difference at 85 is unlikely to be a simple readout of today's estradiol panel.

And yet estrogen wasn't a bystander. In the same analysis, estrogen levels significantly predicted executive functioning — though notably not memory. Testosterone predicted neither. The picture that emerges is one of partial, domain-specific hormonal influence layered on top of a larger, more durable sex difference whose origins likely reach back decades: cumulative lifetime exposure to sex hormones, sex-linked patterns of cardiovascular and metabolic risk, and education and occupational histories that differed sharply for women now in their ninth decade.

For readers navigating perimenopause, menopause, and the long horizon beyond, the practical reading of this study is not that women are cognitively safe. Women still bear roughly two-thirds of the global Alzheimer's burden, a fact this study does not address. What it does address is the assumption — quietly baked into much of the cognitive-aging guidance now circulating — that a single, unisex playbook is the right starting point.

If executive function and memory diverge by sex into the 80s, then the baseline against which decline is measured should probably diverge too. A man whose verbal memory drops below the male average at 78 is in a different clinical position than a woman whose verbal memory drops below the female average at the same age. Screening tools that ignore this risk under-identifying women whose decline is real but still places them above a male-anchored cutoff — and over-identifying men whose performance is normal for their sex.

The hormonal piece is where care is most warranted. The finding that estrogen predicts executive function in this cohort is consistent with a broader, still-unresolved literature on estrogen and the aging brain. It is not, on its own, evidence that hormone therapy initiated in the eighth decade will improve cognition. The study was observational, it measured circulating hormones rather than testing an intervention, and the authors are explicit that current gonadal hormone levels did not mediate the sex difference they found. That is a ceiling on how far the result can be stretched.

What this work most usefully does is widen the frame. For years, women over 55 have been handed cognitive-aging advice that was, in practice, derived from research populations skewed male and middle-aged. The result has been guidance that often feels imprecise: useful in broad strokes, vague where it counts. A study like this one — modest in size, careful in its claims, focused on an age band most research ignores — is part of a slow correction.

The correction is not that women's brains are better. It is that women's brains are different, in ways that persist far longer than the field assumed, and that the protocols built to protect them should reflect that. If your clinician is still working from a unisex template, this is a reasonable study to bring to the conversation. The evidence is moderate, not definitive. But the direction is clear enough to act on as one input among several — and to keep watching as larger cohorts and intervention trials catch up.